Skip to main content
SpringerLink
Log in

Pfizer-BioNTech COVID-19 vaccine safe in older Koreans

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Choi YY, et al. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older. Journal of Korean Medical Science 36: e318, No. 45, 22 Nov 2021. Available from: URL: http://doi.org/10.3346/jkms.2021.36.e318

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pfizer-BioNTech COVID-19 vaccine safe in older Koreans. Reactions Weekly 1884, 10 (2021). https://doi.org/10.1007/s40278-021-06331-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-06331-8

Search

Navigation